Table of contents:
Fostimon is a medication used to stimulate egg production in women who are not ovulating and who have not responded to other treatments. It is used in assisted reproductive technology, specifically in vitro fertilization (IVF) cycles.
Fostimon contains urofollitropin, which is a form of follicle stimulating hormone (FSH). It works by stimulating egg production in the ovaries and promoting ovulation in women who are not ovulating or who have not responded to other treatments.
Use and Dosage
Fostimon is available in different strengths, including 75 IU and 150 IU, and is administered via injection. To use a Fostimon vial, you must first prepare the solution just before injection. One vial is for single use only.
To prepare the Fostimon injection, follow these steps:
- The ampoule neck is designed to break easily below the coloured dot. Gently flick the top of the ampoule to dislodge any remaining liquid and then hold the ampoule with the colored dot facing away from you. Snap off the top of the ampoule and use a cloth or ampoule-snapper to hold it securely. Place the opened ampoule upright on a clean surface.
- Remove the plastic cap from the powder vial by pushing it upwards. Disinfect the rubber stopper on top of the vial using an alcohol swab and allow it to dry.
- Attach the reconstitution needle (a large needle) to the syringe and remove the protective cap. Hold the syringe in one hand and insert the needle into the opened solvent ampoule, drawing up all the solvent into the syringe. Attach the protective cap to the needle and carefully set the syringe down on the surface.
- Slowly inject the solvent into the powder vial through the middle of the rubber stopper. Press the plunger down firmly to squirt all the solution onto the powder. Do not shake the vial, but gently roll it between your hands until the powder is completely dissolved, taking care to avoid creating foam.
- Once the powder is dissolved, remove the needle shield and, while the needle is still inserted, turn the vial upside down, making sure the needle tip is below the level of the liquid. Slowly pull the plunger up to draw all the solution up into the syringe. Check that the reconstituted solution is clear and colourless before using it.
By following these steps carefully, you should be able to prepare the injection accurately and safely. Always follow the instructions provided by your healthcare provider when using Fostimon, and never reuse a vial or share your injection equipment with others.
Common Side Effects of Fostimon (Urofollitropin):
- Over-stimulation of the ovaries (ovarian hyperstimulation), causing the production of many eggs
- Bloating of the abdomen
- Pain at the site of injection
Serious Side Effects of Fostimon (Urofollitropin):
- Breast enlargement or breast pain
- Difficulty stopping bleeding
- Hot flush
- Mood swings
- Nausea, indigestion, or abdominal pain
- Nose bleeds
- Overactive thyroid gland
- Pain at the injection site
- Redness, pain, and bruising at the injection site
- Skin rash or itch
Forms and Strength
Fostimon (Urofollitropin) is available in the following forms and strength:
- Urofollitropin injection is only used under medical supervision and should not be self-administered.
- Urofollitropin should only be used in women who have been properly screened before treatment to exclude any contraindications such as pregnancy, ovarian cysts, abnormal vaginal bleeding, or tumors of the reproductive tract.
- There is a risk of ovarian hyperstimulation syndrome (OHSS) with Urofollitropin, which can cause fluid buildup in the lungs, heart failure, and other serious complications. Patients should be carefully monitored for signs of OHSS during treatment.
- Urofollitropin may increase the risk of multiple pregnancies, which can also increase the risk of premature birth and other complications.
- Urofollitropin may interact with other drugs, so patients should inform their healthcare provider of all the medications, supplements, and herbs they are taking before starting treatment with Urofollitropin.
- Urofollitropin may cause allergic reactions in some patients, so patients should seek medical attention immediately if they experience symptoms such as rash, itching, or difficulty breathing.
- Urofollitropin should not be used in patients with a history of pituitary or ovarian tumor, thyroid or adrenal gland disorder, or uncontrolled thyroid or adrenal gland disorder.
- Urofollitropin should not be used in patients with a history of blood clots or stroke, as it may increase the risk of recurrence.
- Urofollitropin may cause mood changes, depression, or other psychiatric symptoms in some patients, so patients should inform their healthcare provider if they experience any changes in mood or behavior during treatment.
- Urofollitropin should not be used in patients who are breastfeeding, as it may pass into breastmilk and harm the nursing infant.
- Urofollitropin should not be used in patients with abnormal thyroid function or adrenal gland function, as it may interfere with hormone regulation.
- Urofollitropin should not be used in men, as it is not indicated for use in males.
Frequently Asked Questions (FAQ)
Can men use Fostimon?
No, Fostimon is not indicated for use in men.
What should I do if I miss a dose of Fostimon?
If you miss a dose of Fostimon, contact your healthcare provider for advice on when to administer the next dose.
How long does treatment with Fostimon last?
The length of treatment with Fostimon can vary depending on the patient's response to treatment and other factors. Patients should follow their healthcare provider's instructions regarding the duration of treatment.
Does Fostimon require a prescription?
Yes, Fostimon requires a prescription from a healthcare provider.
Can Fostimon be used for menopausal hormone replacement therapy?
No, Fostimon is not indicated for use in menopause hormone replacement therapy.
It's important to purchase Fostimon from verified Canadian pharmacy.